A Prospective Study Investigating the Effect of Sofosbuvir and other Antivirals on the Cardiac Conduction System in Patients with Hepatitis C Virus Infection
Latest Information Update: 07 Dec 2017
At a glance
- Drugs Daclatasvir (Primary) ; Dasabuvir (Primary) ; Elbasvir/grazoprevir (Primary) ; Ledipasvir/sofosbuvir (Primary) ; Ombitasvir/paritaprevir/ritonavir (Primary) ; Ribavirin (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions
- 07 Dec 2017 New trial record
- 01 Nov 2017 Results presented at the 25th United European Gastroenterology Week.